Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
9.51
+0.50 (5.55%)
At close: Apr 7, 2026, 4:00 PM EDT
10.01
+0.50 (5.26%)
Pre-market: Apr 8, 2026, 7:42 AM EDT
Fortrea Holdings Market Cap
Fortrea Holdings has a market cap or net worth of $889.19 million as of April 8, 2026. Its market cap has increased by 12.41% in one year.
Market Cap
889.19M
Enterprise Value
1.83B
1-Year Change
12.41%
Ranking
Category
Stock Price
$9.51
Market Cap Chart
Since June 16, 2023, Fortrea Holdings's market cap has decreased from $2.67B to $889.19M, a decrease of -66.66%. That is a compound annual growth rate of -32.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 889.19M | -44.21% |
| Dec 31, 2025 | 1.59B | -4.72% |
| Dec 31, 2024 | 1.67B | -46.02% |
| Dec 29, 2023 | 3.10B | 16.21% |
| Jun 16, 2023 | 2.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 927.98M |
| UroGen Pharma | 916.20M |
| GH Research | 903.77M |
| Janux Therapeutics | 902.74M |
| Phathom Pharmaceuticals | 893.58M |
| ORIC Pharmaceuticals | 892.18M |
| Annexon | 882.61M |
| Arbutus Biopharma | 875.74M |